Marek Slomczynski
Overview
Explore the profile of Marek Slomczynski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Budzianowski J, Faron W, Rzezniczak J, Slomczynski M, Hiczkiewicz D, Olejniczak J, et al.
J Clin Med
. 2024 Feb;
13(4).
PMID: 38398410
Background: The factors that determine the necessity of coronary artery revascularization in patients with unstable angina (UA) have been supported by limited data. Therefore, this study aimed to identify the...
2.
Machine learning model for predicting late recurrence of atrial fibrillation after catheter ablation
Budzianowski J, Kaczmarek-Majer K, Rzezniczak J, Slomczynski M, Wichrowski F, Hiczkiewicz D, et al.
Sci Rep
. 2023 Sep;
13(1):15213.
PMID: 37709859
Late recurrence of atrial fibrillation (LRAF) in the first year following catheter ablation is a common and significant clinical problem. Our study aimed to create a machine-learning model for predicting...
3.
Kasprzak D, Kaczmarek-Majer K, Rzezniczak J, Klamecka-Pohl K, Ganowicz-Kaatz T, Slomczynski M, et al.
J Clin Med
. 2023 Aug;
12(15).
PMID: 37568355
(1) Background: Assessment of cognitive function is not routine in cardiac patients, and knowledge on the subject remains limited. The aim of this study was to assess post-myocardial infarction (MI)...
4.
Elikowski W, Angerer D, Fertala N, Zawodna-Marszalek M, Greberska W, Ganowicz-Kaatz T, et al.
Pol Merkur Lekarski
. 2023 Mar;
51(1):88-94.
PMID: 36960905
Takotsubo syndrome (TTS) has been reported in various clinical conditions. Coronary artery fistula (CAF) is diagnosed in 0.2- 0.4% of patients undergoing coronary angiography. Pathologic communication between coronary artery (e.g.,...
5.
Kasprzak D, Ganowicz-Kaatz T, Rzezniczak J, Slomczynski M, Kaczmarek-Majer K, Budzianowski J, et al.
Kardiol Pol
. 2023 Mar;
81(5):505-507.
PMID: 36871300
No abstract available.
6.
Slomczynski M, Rzezniczak J, Kasprzak D, Bugajski P, Bolewski A, Burchardt P
Pol Arch Intern Med
. 2022 Jul;
132(7-8).
PMID: 35833894
No abstract available.
7.
Kasprzak D, Rzezniczak J, Ganowicz T, Luczak T, Slomczynski M, Hiczkiewicz J, et al.
Glob Heart
. 2021 Aug;
16(1):53.
PMID: 34381674
According to the World Health Organization (WHO) forecasts, in 2030, the number of people suffering from dementia will reach 82 million people worldwide, representing a huge burden on health and...
8.
Karazniewicz-Lada M, Krzyzanska D, Danielak D, Rzezniczak J, Glowka F, Slomczynski M, et al.
Eur J Clin Pharmacol
. 2020 Jan;
76(3):419-430.
PMID: 31897532
Purpose: Impaired antiplatelet effect of clopidogrel (CLP) can result from drug-drug interactions and genetic polymorphisms of drug-metabolizing enzymes. The aim of the study was to evaluate the effect of genetic...
9.
Elikowski W, Malek-Elikowska M, Ganowicz-Kaatz T, Fertala N, Zawodna M, Baszko A, et al.
Pol Merkur Lekarski
. 2019 Nov;
47(280):144-149.
PMID: 31760397
A Case Report: The authors describe TLVH/T in a 30-year-old female with a history of chronic emotional stress and depression treated with venlafaxine (75 mg twice a day). She suffered...
10.
Karazniewicz-Lada M, Rzezniczak J, Glowka F, Gumienna A, Dolatowski F, Slomczynski M, et al.
Biomed Pharmacother
. 2019 May;
116:108991.
PMID: 31136946
Possible interaction between clopidogrel and CYP3A4-metabolised atorvastatin or non-CYP3A4-metabolised rosuvastatin was investigated based on pharmacokinetic parameters of clopidogrel and its metabolites as well as the platelet reactivity test in patients...